期刊
CURRENT MEDICINAL CHEMISTRY
卷 20, 期 5, 页码 671-693出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/092986713804999312
关键词
CK2; protein kinases; enzymes; kinase inhibitors; multi kinase inhibitors; cell cycle; cell signaling; apoptosis; cancer; neurodegenerative diseases; infections
资金
- University of Padova, Italy
- Italian Ministry for University and Research (MIUR), Rome, Italy
- AIRC (Associazione Italian per la Ricerca sul Cancro) [IG10312]
- Fondazione per lo studio della Fibrosi Cistica [FFC3/2011]
Protein kinase CK2 (Casein Kinase 2) is an essential, ubiquitous and highly pleiotropic protein kinase, implicated in several human diseases. In the last decade, several inhibitors of CK2, have been discovered and characterized to be ATP-competitive compounds. However, only one of them, CX-4945, has recently completed Phase I clinical trial as potential anticancer drug. In this review, we report all chemical classes of CK2 inhibitors available in literature, focusing our attention on conventional ATP-competitive and on non ATP-competitive inhibitors, which could represent a new frontier in CK2 inhibition and, consequently, a promising field of study in discovering new drug candidates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据